Drug companies control news with $$$$ in ads The Deeper

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
115
Drug companies control news with $$$$ in ads

The Deeper Reason For Drug Ads On Television

https://www.naturalblaze.com/2018/03/deeper-r...ision.html

By Jon Rappoport

Television viewers are inundated with drug ads from Big Pharma. It’s a flood.

Have you ever heard of these drugs? Otezla, Xeljanz, Namzaric, Keytruda, Breo, Cosentyz? Not likely. If you have, do you know what conditions they treat? Highly unlikely. But there they are, splashed in commercials.

Why? Who is going to remember to ask their doctor whether these and other obscure meds are right for them?

What’s going on here?

The answer is: IT DOESN’T MATTER WHAT DRUGS ARE BEING ADVERTISED.

If Pharma can pay enough TOTAL money for ads, for ALL drugs, and dominate the allotted TV time for commercials, it can control the news—and that is exactly what it wants to do.

Pharmaceutical scandals are everywhere. Reporting on them, wall to wall, isn’t good for the drug business. However, as an industry ponying up billions of dollars for TV ads, Pharma can limit exposure and negative publicity. It can (and does) say to television networks: If you give us a hard time on the news, we’ll take our ad money and go somewhere else. Boom. End of problem.

Face it, the billions of dollars Pharma is paying for TV ads are a drop in the bucket, compared with its profits gained from selling the drugs. The ads are a good investment. As a bribe.

Control the news.

There is another reason for the insane flood of TV drug ads:

By their sheer number, they convince viewers that medical drugs (no matter what they are) are absolutely necessary.

Hour by hour, viewers numbly watch drug commercial after commercial. The overall message is: To keep illness from your door, to cure illness, to alleviate illness, you must take these medicines. THIS IS LIFE IN THE 21ST CENTURY. You’re all sick, and you need help, and this is the ONLY kind of help there is.

The drug companies could invent names of fake drugs that don’t even exist, advertise them in a cascade on television, with the same intent. DRUGS ARE AS VITAL TO LIFE AS WATER OR AIR.
But what about all those dire warnings of side effects from the drugs? By law, the companies must include them in their commercials. Well, the companies have calculated that, on balance, the stark, front-line, unending message of DRUGS, DRUGS, AND MORE DRUGS will outweigh the warnings in viewers’ minds.

If the television audience is nailed with the idea that they can’t escape; that their health always hangs in the balance; that dire illnesses are always waiting in the shadows to strike; that the slightest ache or pain could be a precursor to a crippling or fatal disease; and drugs are the only solution and protection—they’re going to overlook the warnings about side effects.

ALL IN ALL, DRUG ADS ARE NEWS.

That’s the approach. Pharma is blasting out 24/7 news asserting modern medicine’s central and commanding role in the life of every human.

It’s a gigantic and stupendous piece of mind control, but when did that ever stop tyrants from inventing reality for the masses?

Implicit in “ask your doctor if drug X is right for you,” is the message: “go to your doctor.” That’s the key. If the ads can put a viewer into the system, he will be diagnosed with something, and he’ll be given a drug for it.

So the drug ads are also promotions for doctors, who are the arbiters and the decision makers. Some kind of medical need (drugs) always exists—and the doctor will tell you what it is. And all patients should OBEY. Even if, in the process, they go broke.

Take the case of Opdivo, a drug that treats squamous non-small cell lung cancer. Cost? $12,500 a month. Patients on Medicare will pay $2500 a month out of their own pockets. And the result?

Wall St. Journal: “In the clinical study on which the Opdivo ad bases its claims, the drug extended median patient survival to 9.2 months from the start of treatment…”

The cancer patient pays $22,500 for nine months of survival, during which the suffering continues, and then he dies.

The ad isn’t mentioning THAT.

The ad relies on the doctor to convince the patient to go along with this lunatic program.

The author of two explosive collections, THE MATRIX REVEALED and EXIT FROM THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at www.nomorefakenews.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
Innventure Faces Major Lawsuit Amidst Market Turmoil

Updated Category News Views 0

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Continue Reading
Webinar Highlights Workforce Skills and AI Tools

Updated Category News Views 3

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

Continue Reading
VitalCore Pioneers Jail Behavioral Health Expansion

Updated Category News Views 4

The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 4

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
Mandeville Pests: Health Dangers Lurking at Home

Updated Category News Views 1

Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...

Continue Reading
Everpure Surges into the S&P 500: A Milestone Move

Updated Category News Views 10

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 3

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices

Updated Category News Views 3

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Teekay Tankers Earnings on the Horizon: What to Expect?

Updated Category News Views 131

Teekay Tankers (NYSE:TNK) drops its quarterly earnings bombshell on February 18, 2026. Traders are already twitching in anticipation of those digits. Analysts have slapped a $2.72 EPS estimate on this puppy, but let’s unpack what that really means when it hits the terminal. Because history suggests expectations can tank quicker than a freight ship in a storm. Past...

Continue Reading
Akamai and Visa Innovate Security Measures for Digital Commerce

Updated Category News Views 84

Akamai and Visa Strive for Enhanced Security Akamai Technologies, Inc. (NASDAQ: AKAM) has joined forces with Visa Inc. (NYSE: V) to revolutionize digital transaction security. This collaboration aims to improve identity verification, user recognition, and overall security within agentic commerce, creating a safer online marketplace. Collaborative Innovation The...

Continue Reading
Top Income Stocks to Consider for Steady Returns

Updated Category News Views 189

Exploring High-Yield Dividend Stocks Investing in dividend stocks can be an excellent way to earn passive income. Many reputable companies offer attractive payouts, and several of these high-quality income generators consistently increase their dividends each year. This trend makes them more appealing compared to the fixed income provided by bonds. Notable companies like...

Continue Reading
Protecting Your Investment: Navigating Class Actions for RXST

Updated Category News Views 167

Protecting Your Investment: Navigating Class Actions for RXST As an investor, being aware of your rights and options is crucial, especially when facing significant legal situations like securities class actions. Recently, an alert was issued for investors of RxSight, Inc. (NASDAQ: RXST) regarding a class action lawsuit that has thrown many into a whirlwind of uncertainty....

Continue Reading
Gulf Investments in the U.S. Expected to Surge with Leadership Change

Updated Category News Views 195

Anticipated Growth of Gulf Investments in the U.S. Emirati billionaire Hussain Sajwani has expressed optimism regarding future investments from the Gulf region into the United States. He believes that under the leadership of President-elect Donald J. Trump, known for his pro-business stance, the U.S. could witness a significant influx of capital from oil-rich nations....

Continue Reading